Atlas Trials

Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma

Clinical trial NCT06365034 · UNKNOWN

Trial details

NCT number
NCT06365034
Sponsor
Qianfoshan Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Carcinoma, Hepatocellular
Start date
2024-03-01
Primary completion
2024-10-01
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.